![]() ![]() Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies. Shioda K, Lau MS, Kraay AN, Nelson KN, Siegler AJ, Sullivan PS, Collins MH, Weitz JS, Lopman BA. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America SARS-CoV-2 cumulative incidence, United States, August-December 2020. Sullivan PS, Siegler AJ, Shioda K, Hall EW, Bradley H, Sanchez T, Luisi N, Valentine-Graves M, Nelson KN, Fahimi M, Kamali A, Sailey C, Lopman BA. Estimated impact of the pneumococcal conjugate vaccine on pneumonia mortality in South Africa, 1999 through 2016: An ecological modelling study. ![]() Kleynhans J, Tempia S, Shioda K, von Gottberg A, Weinberger DM, Cohen C. Cumulative incidence of SARS-CoV-2 infections among adults in Georgia, USA, August-December 2020. ![]() Annals of epidemiologyĬhamberlain AT, Toomey KE, Bradley H, Hall EW, Fahimi M, Lopman BA, Luisi N, Sanchez T, Drenzek C, Shioda K, Siegler AJ, Sullivan PS. ![]() A framework for monitoring population immunity to SARS-CoV-2. Lopman BA, Shioda K, Nguyen Q, Beckett SJ, Siegler AJ, Sullivan PS, Weitz JS. Incorporating Information on Control Diseases Across Space and Time to Improve Estimation of the Population-level Impact of Vaccines. Shioda K, Cai J, Warren JL, Weinberger DM. How to interpret the total number of SARS-CoV-2 infections. Post-lockdown changes of age-specific susceptibility and its correlation with adherence to social distancing measures. Lau MSY, Liu C, Siegler AJ, Sullivan PS, Waller LA, Shioda K, Lopman BA. medRxiv : the preprint server for health sciences Nationally Representative Social Contact Patterns among U.S. Nelson KN, Siegler AJ, Sullivan PS, Bradley H, Hall E, Luisi N, Hipp-Ramsey P, Sanchez T, Shioda K, Lopman BA. Nationally representative social contact patterns among U.S. Daniel Weinberger, Virginia Pitzer, and Joshua Warren at Yale School of Public Health in August 2020. She had worked in the Division of Viral Diseases at the Centers for Disease Control and Prevention (CDC) in Atlanta from 2014-2016 as an ORISE fellow. She obtained a Doctor of Veterinary Medicine (DVM) from the University of Tokyo in 2012 and a Master of Public Health (MPH) from Emory University in 2014. Her projects focus on One Health issues in low- and middle-income countries in the Freeman Lab and COVID-19 modeling in the Lopman Lab. She works at Emory University as an epidemiologist in two labs: the Freeman Lab in the Department of Environmental Health and the Lopman Lab in the Department of Epidemiology. She is interested in modeling the transmission of pathogens among/between humans, animals, and the environment in order to understand how to best mitigate the health risks. Kayoko is a Japanese veterinarian and infectious disease epidemiologist/modeler. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |